Ingebrigt Talstad

794 total citations
54 papers, 614 citations indexed

About

Ingebrigt Talstad is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Ingebrigt Talstad has authored 54 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 13 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Ingebrigt Talstad's work include Blood properties and coagulation (12 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and Erythrocyte Function and Pathophysiology (8 papers). Ingebrigt Talstad is often cited by papers focused on Blood properties and coagulation (12 papers), Venous Thromboembolism Diagnosis and Management (10 papers) and Erythrocyte Function and Pathophysiology (8 papers). Ingebrigt Talstad collaborates with scholars based in Norway, Sweden and Germany. Ingebrigt Talstad's co-authors include E Gjone, K. Rootwelt, Christen J. Bang, Arnold Berstad, Helge Dalen, Hrafnkell Thordarson, Inge Romslo, Bjørn Haneberg, C. O. Solberg and Steinar Sørnes and has published in prestigious journals such as JAMA, Blood and Journal of Leukocyte Biology.

In The Last Decade

Ingebrigt Talstad

49 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingebrigt Talstad Norway 14 142 129 129 121 120 54 614
R Beckmann Austria 12 85 0.6× 187 1.4× 84 0.7× 128 1.1× 116 1.0× 31 710
S Inceman Türkiye 8 85 0.6× 52 0.4× 300 2.3× 151 1.2× 84 0.7× 27 647
P. J. Morris United Kingdom 14 73 0.5× 96 0.7× 91 0.7× 75 0.6× 193 1.6× 34 692
John E. Curtis Canada 14 33 0.2× 84 0.7× 226 1.8× 166 1.4× 110 0.9× 18 605
Noga Manny Israel 18 109 0.8× 138 1.1× 369 2.9× 196 1.6× 92 0.8× 49 1.2k
Stella B. Kontras United States 16 78 0.5× 77 0.6× 72 0.6× 110 0.9× 82 0.7× 35 568
M.J. Allington United Kingdom 13 44 0.3× 24 0.2× 189 1.5× 163 1.3× 60 0.5× 26 530
J Hugues Belgium 11 39 0.3× 71 0.6× 139 1.1× 100 0.8× 55 0.5× 36 552
Chaim Kaplinsky Israel 19 128 0.9× 68 0.5× 225 1.7× 170 1.4× 135 1.1× 61 892
John Percy Canada 21 59 0.4× 130 1.0× 103 0.8× 67 0.6× 192 1.6× 46 1.1k

Countries citing papers authored by Ingebrigt Talstad

Since Specialization
Citations

This map shows the geographic impact of Ingebrigt Talstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingebrigt Talstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingebrigt Talstad more than expected).

Fields of papers citing papers by Ingebrigt Talstad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingebrigt Talstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingebrigt Talstad. The network helps show where Ingebrigt Talstad may publish in the future.

Co-authorship network of co-authors of Ingebrigt Talstad

This figure shows the co-authorship network connecting the top 25 collaborators of Ingebrigt Talstad. A scholar is included among the top collaborators of Ingebrigt Talstad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingebrigt Talstad. Ingebrigt Talstad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Talstad, Ingebrigt. (2000). Why Is the Standardization of Prothrombin Time a Problem?. Pathophysiology of Haemostasis and Thrombosis. 30(5). 258–267. 8 indexed citations
2.
Talstad, Ingebrigt. (1994). Simplified Calibration of Prothrombin Time Assays. Pathophysiology of Haemostasis and Thrombosis. 24(1). 14–21. 1 indexed citations
3.
Talstad, Ingebrigt, et al.. (1994). Warfarin resistance due to malabsorption. Journal of Internal Medicine. 236(4). 465–467. 11 indexed citations
4.
Keldsen, Nina, Ole Weis Bjerrum, Inger Marie S. Dahl, et al.. (1993). Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase III study. European Journal Of Haematology. 51(2). 80–85. 3 indexed citations
5.
Talstad, Ingebrigt. (1993). Which Coagulation Factors Interfere with the One-Stage Prothrombin Time?. Pathophysiology of Haemostasis and Thrombosis. 23(1). 19–25. 9 indexed citations
6.
Bang, Christen J., Bettina Riedel, Ingebrigt Talstad, & Aud Katrine Herland Berstad. (1992). Haemorrhagic Effect of Enoxaparin, a Low Molecular Weight Heparin: Comparison with Unfractionated Heparin in Humans. Scandinavian Journal of Gastroenterology. 27(11). 924–928. 5 indexed citations
7.
Gimsing, Peter, Ole Weis Bjerrum, Stein A. Evensen, et al.. (1991). Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP‐regimen): a phase II study. British Journal of Haematology. 77(1). 73–79. 12 indexed citations
8.
Bang, Christen J., Arnold Berstad, & Ingebrigt Talstad. (1991). Haemorrhagic Effects of Unfractionated and Two Low Molecular Weight Heparins, Enoxaparin and Fragmin, in Rats. Pathophysiology of Haemostasis and Thrombosis. 21(1). 30–36. 11 indexed citations
9.
Bang, Christen J., Arnold Berstad, & Ingebrigt Talstad. (1990). Gastric Mucosal Bleeding after Unfractionated and Low Molecular Weight Heparin in Rats. Scandinavian Journal of Gastroenterology. 25(4). 379–382. 6 indexed citations
10.
Romslo, Inge & Ingebrigt Talstad. (1988). Day‐to‐day variations in serum iron, serum iron binding capacity, serum ferritin and erythrocyte protoporphyrin concentrations in anaemic subjects. European Journal Of Haematology. 40(1). 79–82. 18 indexed citations
11.
Korsbrekke, Knut & Ingebrigt Talstad. (1987). Revised Standardization Method of the One-Stage Prothrombin Time. Pathophysiology of Haemostasis and Thrombosis. 17(6). 313–320. 1 indexed citations
12.
Næss, Are, Ingebrigt Talstad, & C. O. Solberg. (1987). Infectious Mononucleosis: Increase of High-Affinity E-Receptor-Bearing Lymphocytes. International Archives of Allergy and Immunology. 83(2). 178–181. 1 indexed citations
13.
Talstad, Ingebrigt. (1985). How Does the Pivka Inhibitor Interfere with the One-Stage Prothrombin Time?. Pathophysiology of Haemostasis and Thrombosis. 15(5). 304–309. 1 indexed citations
14.
Talstad, Ingebrigt. (1984). Electronic Counting of Spinal Fluid Cells. American Journal of Clinical Pathology. 81(4). 506–511. 5 indexed citations
15.
Talstad, Ingebrigt, et al.. (1975). Graded gastrectomy for duodenal ulcer -- a five-year prospective study.. PubMed. 33. 1–27. 3 indexed citations
16.
Talstad, Ingebrigt, et al.. (1974). HYPOGLYCEMIA CAUSED BY AN INTRATHORACIC TUMOUR. Acta Medica Scandinavica. 196(1-6). 347–351. 5 indexed citations
17.
Talstad, Ingebrigt, K. Rootwelt, & E Gjone. (1973). Thrombocytosis in Ulcerative Colitis and Crohn’s Disease. Scandinavian Journal of Gastroenterology. 8(2). 135–138. 107 indexed citations
18.
Talstad, Ingebrigt. (1971). INFLUENCE OF PROTEINURIA ON THE QUALITATIVE AND QUANTITATIVE EXAMINATION OF LEUKOCYTES IN URINE. Acta Medica Scandinavica. 190(1-6). 149–154. 4 indexed citations
19.
Talstad, Ingebrigt. (1971). THE MORPHOLOGY OF THE ERYTHROCYTE SEDIMENTATION RATE (ESR). Acta Medica Scandinavica. 190(1-6). 7–10. 6 indexed citations
20.
Talstad, Ingebrigt. (1966). [In vitro studies of leukocytes by the Sternheimer-Malbin staining method].. PubMed. 75(13). 352–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Beckmann Breakdown of academic impact, for papers by S Inceman Breakdown of academic impact, for papers by P. J. Morris Breakdown of academic impact, for papers by John E. Curtis Breakdown of academic impact, for papers by Noga Manny Breakdown of academic impact, for papers by Stella B. Kontras Breakdown of academic impact, for papers by M.J. Allington Breakdown of academic impact, for papers by J Hugues Breakdown of academic impact, for papers by Chaim Kaplinsky Breakdown of academic impact, for papers by John Percy
Rankless by CCL
2026